Published in Diabetologia on April 21, 2011
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol (2015) 1.74
The Genetic Landscape of Renal Complications in Type 1 Diabetes. J Am Soc Nephrol (2016) 1.44
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ (2011) 1.26
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) (2015) 1.14
Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2013) 1.01
Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J Am Soc Nephrol (2013) 0.98
Infant and toddler type 1 diabetes: complications after 20 years' duration. Diabetes Care (2012) 0.89
Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. Cardiovasc Diabetol (2013) 0.83
Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations. Diabetologia (2012) 0.83
Microvascular complications in adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol (2013) 0.83
Tubulointerstitial disease in diabetic nephropathy. Int J Nephrol Renovasc Dis (2014) 0.82
Sugar, sex, and TGF-β in diabetic nephropathy. Semin Nephrol (2012) 0.80
Association of glycemic status with impaired lung function among recipients of a health screening program: a cross-sectional study in Japanese adults. J Epidemiol (2014) 0.80
Diabetic nephropathy: is ESRD its only heritable phenotype? J Am Soc Nephrol (2013) 0.80
The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy. Diabetologia (2011) 0.78
[Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes]. Wien Klin Wochenschr (2012) 0.76
Genetics and Epigenetics of Diabetic Nephropathy. Kidney Dis (Basel) (2015) 0.76
Influence of Age at Diagnosis and Time-Dependent Risk Factors on the Development of Diabetic Retinopathy in Patients with Type 1 Diabetes. J Diabetes Res (2016) 0.75
Contribution of sex hormones in the progression of diabetic microvascular diseases. J Diabetes Investig (2012) 0.75
Diabetic women suffer more years of life lost than diabetic men. Int J Endocrinol (2014) 0.75
Progress in Defining the Genetic Basis of Diabetic Complications. Curr Diab Rep (2017) 0.75
[Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes]. Wien Klin Wochenschr (2016) 0.75
Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int (2007) 3.17
The awakening cortisol response: methodological issues and significance. Stress (2004) 2.88
Transition in specification of embryonic metazoan DNA replication origins. Science (1995) 2.82
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes (1996) 2.33
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med (2011) 2.30
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care (2011) 2.20
What is the benefit of increasing the sulfonylurea dose? Ann Intern Med (1993) 2.16
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia (2015) 2.05
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia (2003) 1.84
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ (1992) 1.60
Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes. Diabet Med (2008) 1.52
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia (2011) 1.51
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation (1997) 1.41
Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes. Diabetes (2015) 1.40
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation (1996) 1.26
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Heritability of proliferative diabetic retinopathy. Diabetes (2008) 1.25
A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia (2010) 1.22
DNA replication-dependent formation of joint DNA molecules in Physarum polycephalum. Mol Cell (2001) 1.20
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes (2008) 1.20
Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics (2011) 1.19
Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care (2009) 1.18
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia (2007) 1.14
A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes (2001) 1.13
[Functional morphology of stria vascularis after treatment with ethacrynic acid or atoxyl (author's transl)]. Arch Otorhinolaryngol (1978) 1.11
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia (2009) 1.11
Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant (2009) 1.10
In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care (1999) 1.09
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia (2010) 1.08
Relationship between lipid profiles and kidney function in patients with type 1 diabetes. Diabetologia (2007) 1.07
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA (2006) 1.04
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care (2008) 1.04
Glucose variability, blood pressure and arterial stiffness in type 1 diabetes. Diabetes Res Clin Pract (2008) 1.03
Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia (2000) 1.01
Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens (2012) 1.01
Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes (1988) 1.00
Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant (1997) 0.99
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia (2009) 0.98
Physical activity and diabetes complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study. Diabetes Care (2007) 0.98
Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care (2013) 0.98
Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia (1998) 0.97
Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism. Diabetes (1999) 0.96
Localization and interactions of vasoactive peptide receptors in renomedullary interstitial cells of the kidney. Kidney Int Suppl (1998) 0.96
Diurnal patterns of salivary cortisol across the adolescent period in healthy females. Psychoneuroendocrinology (2008) 0.95
Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes. J Clin Endocrinol Metab (2001) 0.94
Endothelial dysfunction in men with small LDL particles. Circulation (2000) 0.94
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes (1998) 0.94
Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology (2011) 0.94
Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes. Diabetologia (1986) 0.94
Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care (2010) 0.94
Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care (1998) 0.94
Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? Diabetologia (2012) 0.92
Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia (2007) 0.91
Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study. Ann Med (2010) 0.91
Early autonomic dysfunction in type 1 diabetes: a reversible disorder? Diabetologia (2009) 0.91
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1993) 0.91
Development of the renal interstitium. Pediatr Nephrol (1999) 0.91
Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. J Intern Med (2009) 0.90
Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy. Nephrol Dial Transplant (2007) 0.90
Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2014) 0.90
The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol (1993) 0.89